Related Experiment Video
Updated: Jul 28, 2026
12:50
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Brain volume loss in MCI predicts dementia
D Erten-Lyons1, D Howieson, M Milar Moore
1Department of Neurology, Oregon Health and Science University, Portland, OR, USA. ertenlyo@ohsu.edu
Neurology
|January 26, 2006
Summary
Mild cognitive impairment (MCI) subjects who developed dementia showed faster temporal horn volume loss than stable MCI patients. This suggests temporal horn atrophy may predict dementia progression in individuals with MCI.
Area of Science:
- Neuroscience
- Gerontology
- Medical Imaging
Background:
- Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
- Identifying biomarkers for dementia progression in MCI is crucial for early intervention.
Purpose of the Study:
- To investigate if temporal horn volume change rates differ between MCI subjects who progress to dementia and those who remain stable.
Main Methods:
- Longitudinal volumetric analysis of temporal horn changes using MRI scans.
- Comparison of atrophy rates in MCI patients who developed dementia versus those who remained stable.
Main Results:
- Significantly greater rates of temporal horn volume loss were observed in MCI subjects who progressed to dementia.
- Temporal horn volume change serves as a potential indicator of neurodegeneration in MCI.
Conclusions:
- Accelerated temporal horn atrophy is associated with progression from mild cognitive impairment to dementia.
- MRI-based volumetric analysis of the temporal horn may aid in predicting dementia development in MCI patients.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...